New trial data suggests Pfizer's acquired obesity treatment could be administered monthly, potentially improving patient compliance compared to weekly alternatives. The midstage results advance the drug toward late-stage testing, though competitive positioning remains uncertain.
STAT · Saturday, 6 June 2026
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
Original source
Read the full article at STATShare this story
Volunteer physicians in La Guaira rapidly repurposed a fast-food restaurant to provide medical care following a seismic event, extending healthcare access when conventional facilities were unavailable. The improvised clinic demonstrates community resilience and medical innovation in resource-constrained conditions.
Al Jazeera · 11 Jul
Pakistan's Supreme Court issued comprehensive anti-harassment guidelines for educational institutions and upheld strict penalties against a headmistress who failed to protect female teachers from sexual harassment. The ruling requires all schools to adopt internal harassment policies, establish independent complaint mechanisms, and display codes of conduct across the country.
Dawn Pakistan · 11 Jul
Brazil's Amazon deforestation fell to its lowest level in ten years, reflecting strengthened enforcement against illegal logging and forest clearing. The milestone supports Lula's commitment to eliminate illegal deforestation by 2030, with implications for global climate and biodiversity.
Al Jazeera · 10 Jul
Every Sunday — the week's most uplifting stories, straight to your inbox. No doom, no noise.
No spam. Unsubscribe anytime. GDPR compliant.